Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...
PURPOSE: To define the maximum-tolerated dose (MTD) and the phase II recommended dose (RD) of ecteinascidin-743 (ET-743) given as a 24-hour continuous infusion every 3 weeks to patients with treatment ...
In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results